Certified by Founder Lodge
Enavate Sciences
United States - ND
INVESTOR
1 Disclosed Funding Rounds $100,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the a
| Company | Date | Round | Raised |
|---|---|---|---|
 CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
 OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
 Sudo Biosciences |
December, 21 ,2023 | Series B | $116,000,000 |
 Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
 Aviceda Therapeutics |
January, 08 ,2025 | Series C | $207,500,000 |
 Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
Northwood | $30,000,000 | (Apr 25, 2025)
Lace | $14,000,000 | (Apr 25, 2025)
Grove Biopharma, Inc. | $30,000,000 | (Apr 25, 2025)
Isembard | $9,000,000 | (Apr 25, 2025)
Steadily Insurance Company | $30,000,000 | (Apr 25, 2025)
